Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Response of Methotrexate Alone Versus Methotrexate Combined With Etanercept for Achieving Minimal/Low Disease Activity in Patients of Juvenile Idiopathic Arthritis

NCT07386587 is registered in ClinicalTrials.gov with University of Child Health Sciences and Children's Hospital, Lahore as lead sponsor.

NCT NCT07386587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07386587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Response of Methotrexate Alone Versus Methotrexate Combined With Etanercept for Achieving Minimal/Low Disease Activity in Patients of Juvenile Idiopathic Arthritis
Lead sponsor
University of Child Health Sciences and Children's Hospital, Lahore
Phase
Phase 3
Overall status
Enrolling by invitation
Start date
January 27, 2026
Completion date
July 27, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

juvenile idiopathic arthritis